Nicholas J. Wang

Lawrence Berkeley National Laboratory — United States

Medicine · Health Sciences

28h-index6.0kcitations135works0.02yr avg

OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Cells and Metastasis(57), Cancer Genomics and Diagnostics(57), Breast Cancer Treatment Studies(23), HER2/EGFR in Cancer Research(14), Melanoma and MAPK Pathways(13)

Publications135 total

Supplementary Figure 2 from Temporal Dissection of Tumorigenesis in Primary Cancers

2023Open Access

Supplementary Figure 3 from Temporal Dissection of Tumorigenesis in Primary Cancers

2023Open Access

Supplementary Table 1 from Temporal Dissection of Tumorigenesis in Primary Cancers

2023Open Access

Supplementary Table 2 from Temporal Dissection of Tumorigenesis in Primary Cancers

2023Open Access

Supplementary Figure 1 from Temporal Dissection of Tumorigenesis in Primary Cancers

2023Open Access

Supplementary Figure 4 from Temporal Dissection of Tumorigenesis in Primary Cancers

2023Open Access

Data from Temporal Dissection of Tumorigenesis in Primary Cancers

2023Open Access

Supplementary Figure 2 from Temporal Dissection of Tumorigenesis in Primary Cancers

2023Open Access

Supplementary Figure Legends 1-4, Methods from Temporal Dissection of Tumorigenesis in Primary Cancers

2023Open Access

Supplementary Figure Legends 1-4, Methods from Temporal Dissection of Tumorigenesis in Primary Cancers

2023Open Access

Supplementary Figure 3 from Temporal Dissection of Tumorigenesis in Primary Cancers

2023Open Access

Supplementary Table 1 from Temporal Dissection of Tumorigenesis in Primary Cancers

2023Open Access

Supplementary Figure 1 from Temporal Dissection of Tumorigenesis in Primary Cancers

2023Open Access

Supplementary Table 2 from Temporal Dissection of Tumorigenesis in Primary Cancers

2023Open Access

Data from Temporal Dissection of Tumorigenesis in Primary Cancers

2023Open Access

Supplementary Figure 4 from Temporal Dissection of Tumorigenesis in Primary Cancers

2023Open Access

Supplementary Figure 1 from Upregulation of ER Signaling as an Adaptive Mechanism of Cell Survival in HER2-Positive Breast Tumors Treated with Anti-HER2 Therapy

2023Open Access

Supplementary figure legend from Upregulation of ER Signaling as an Adaptive Mechanism of Cell Survival in HER2-Positive Breast Tumors Treated with Anti-HER2 Therapy

2023Open Access

Supplementary figure legend from Upregulation of ER Signaling as an Adaptive Mechanism of Cell Survival in HER2-Positive Breast Tumors Treated with Anti-HER2 Therapy

2023Open Access

Data from Upregulation of ER Signaling as an Adaptive Mechanism of Cell Survival in HER2-Positive Breast Tumors Treated with Anti-HER2 Therapy

2023Open Access

page 1 of 7Next →